IIM
AVIR icon

INTECH Investment Management’s Atea Pharmaceuticals AVIR Stock Holding History

INTECH Investment Management’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.4K Sell
16,655
-185
-1% -$920 ﹤0.01% 1987
2026
Q1 		$90.6K Sell
16,840
-16,387
-49% -$75.3K ﹤0.01% 1910
2025
Q4 		$119K Hold
33,227
– – ﹤0.01% 2125
2025
Q3 		$96.4K Sell
33,227
-11,392
-26% -$38.9K ﹤0.01% 2277
2025
Q2 		$161K Hold
44,619
– – ﹤0.01% 2161
2025
Q1 		$133K Buy
44,619
+8,630
+24% +$26.9K ﹤0.01% 2236
2024
Q4 		$121K Buy
35,989
+25,278
+236% +$84K ﹤0.01% 2168
2024
Q3 		$35.9K Buy
+10,711
New +$38.8K ﹤0.01% 2002

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

INTECH Investment Management's AVIR Position: Q2 2026 in Review

INTECH Investment Management reduced its Atea Pharmaceuticals (AVIR) stake by 1.1% in Q2 2026, selling an estimated $920 and leaving 16,655 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1987.

INTECH Investment Management first reported a position in AVIR in Q3 2024 and has held it in 8 quarters since. The position peaked at $161K in Q2 2025. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • INTECH Investment Management held 16,655 shares of Atea Pharmaceuticals worth $77.4K as of Q2 2026.
  • INTECH Investment Management sold 185 Atea Pharmaceuticals shares in Q2 2026, an estimated $920.
  • Atea Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1987 holding.
  • INTECH Investment Management first reported a position in Atea Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Atea Pharmaceuticals position peaked at $161K in Q2 2025.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.